Business programme 2020

New Paradigm of Healthcare: Responding to Global Challenges

Plenary session The 2020 pandemic has created a number of economic and social challenges for governments and society, but has also demonstrated the soundness of the existing healthcare system and served as a powerful catalyst for its transformation. Effective and important regulatory initiatives and solutions have been implemented in a short time under difficult conditions, including a focus on digitalisation and remote formats of interaction with patients, the practice of inpatient substitution techniques, and the introduction of tools to sell drugs online, among others. Medical institutions in Russia have managed their work so that both patients with viral infections and patients who need routine care for chronic diseases can receive assistance in a fairly short time. This has all made it possible to take a fresh look at the utilisation of the resources that are being created as part of the national Healthcare project using both the country’s own potential and the experience of international cooperation. In the realities of the pandemic, improving human resource potential, searching for new approaches, and analysing current strategies in order to optimise and modernise them have become the key focuses of developing the healthcare system. This experience should be taken into account as much as possible and used in the future. Within the context of the patient-centred approach, the healthcare system of the future should contribute to the comprehensive improvement of all aspects of human life and health.
• How has the global healthcare system transformed throughout the world, and how has international experience influenced the effectiveness of decision-making in Russia during the pandemic?
• Which solutions will determine how the national healthcare system of the future develops?
• What revolutionary technologies and innovative approaches will have to be introduced in the healthcare system to reach the planned target numbers?
• What steps should be taken to promptly reform the system used to train and recruit medical personnel?
• What areas in the public healthcare system need to be transformed to help reach the new targets and provide the citizens of the Russian Federation with a long and high-quality life?
• How should responsibility for the health and longevity of the nation be distributed between the healthcare system, business, and citizens themselves?

Moderator:

Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24

Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.

Panellists:

Stanislav Voskresensky — Governor of Ivanovo Region

In 1998 graduated from Plekhanov Russian University of Economics with a degree in International Economic Relations.
1995-1999 – worked on tax issues in Russian and foreign assurance firms.
1999-2004 – Financial Director for organizations involved in specialized subterranean engineering and construction.
2004-2008 – Deputy Director of the President’s Expert Commission.
2008-2012 – Deputy Minister of Economic Development of the Russian Federation.
2012-2014 – Deputy Presidential Envoy to the Northwestern Federal District. He was responsible for coordinating the efforts of federal authorities in developing Kaliningrad Region.
Since August, 19, 2014 – Deputy Minister of Economic Development of the Russian Federation.
He heads the Russian Secretariat of the Intergovernmental Russian-Chinese Commission on Investment Cooperation. He heads the task force on the advancement of Russia’s economic Interests in the Asia-Pacific region under the Government Commission on Economic Development and Integration.
On October 10, 2018, assumed the post of Governor of the Ivanovo Region

Galina Karelova — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation

Deputy Chairperson of the Federation Council of the Russian Federation
Born on 29 June 1950 in the city of Nizhnyaya Salda, Sverdlovsk Region. In 1972, she graduated from the Sergei Kirov Urals Polytechnic Institute with a degree in engineering and economics. PhD in Economics and DSc in Social Sciences, professor. For 20 years she was engaged in teaching and research. Author of over 150 papers on economic, social and political issues.
Since 1990 – delegate, Deputy Speaker (1992–1993) of the Sverdlovsk Regional Parliamentarian Council.
1994–1996 – Deputy of the Council of Federation of the Federal Assembly of the Russian Federation, Chairperson of the Federation Council Committee on Social Policy.
1996–1997 – Deputy of the State Duma of the Federal Assembly of the Russian Federation, Chairman of the Subcommittee on International Humanitarian, Scientific and Cultural Cooperation of the State Duma Committee on International Affairs.
Since 1997 – Deputy and since 2000 – First Deputy Minister of Labour and Social Affairs of the Russian Federation.
April 2003 – March 2004 – Deputy Prime Minister of the Russian Federation on Social Affairs.
April 2004 – December 2007 – Chairperson of the Social Insurance Fund of the Russian Federation.
On 2 December 2007, she was elected a deputy to the Fifth State Duma, Deputy Speaker of the State Duma Committee on Budget and Taxes.
On 4 December 2011, she was elected a deputy to the Sixth State Duma, First Deputy Chair of the State Duma Committee on Labour, Social Policy and Veteran Affairs.
Since 22 September 2014, she is a Representative of the executive authority of the Voronezh Region in the Federation Council. Deputy Speaker of the Federation Council of the Federal Assembly of the Russian Federation, member of the Federation Council Committee on Social Policy. Initiator and drafter of more than 40 laws, including laws on social protection. Full State Counsellor 1st Class of the Russian Federation. Decorated with state orders and medals.

Hans Henri P. Kluge — Regional Director for Europe, World Health Organization

Mikhail Murashko — Minister of Health of the Russian Federation

Born on January 9, 1967 in Sverdlovsk.
1986-1988 – served in the USSR Army.
1992 – graduated from Ural State Medical Institute.
August 1992 – March 1996 – intern; Obstetrician Gynecologist, Komi Republic Hospital in Syktyvkar.
March 1996 – November 1996 – Deputy Medical Superintendent for Consulting and Diagnostics, Medical Superintendent, Komi Republic Perinatal Center in Syktyvkar.
November 1996 – December 1999 – Medical Superintendent, Komi Republic Medical Group in Syktyvkar.
January 2000 – March 2006 - Medical Superintendent, Komi Republic Perinatal Center under Komi Republic Agency of Health Care, Syktyvkar.
March 2006 – February 2011 – Minister of Health Care, Komi Republic.
February 2011 – June 2012 – Head of Department, Obstetrics and Gynecology Department (offers a course of pediatrics), Kirov State Medical Academy under the Ministry of health Care of the Russian Federation, Syktyvkar.
July 2012 – March 2013 – Deputy Head, Federal Service for Health Care Supervision, Moscow.
July 2013 – July 2015 – acting Head, Federal Service for Health Care Supervision.
July 14, 2015 till present time – Head of the Federal Service for Health Care Supervision (has the title of the Full State 2-nd Class Counsellor of the Russian Federation).
1999 – Doctor of Medicine.
2004 – postgraduate degrees in Obstetrics/Gynecology and Public Health Care Administration.
Board certified in Obstetrics/Gynecology and Public Health Care Administration.
Editor-in-Chief and Founder, Human Health in the North Journal. Editorial Board Member, Children’s Health Care in the North West Journal.

Anna Popova — Head, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Ms. Popova, M.D., has a degree in medicine and prophylactics, professor in medical hygiene.
Worked as an epidemiologist, chief of epidemiology at Budennovsk hospital, chief epidiemologist in State Center in Serpukhov and Pushino, deputy head of Rospoterbnadzor in Moscow oblast, head of HR or Rospoterbnadzor and deputy chief of Rospotrebnadzor .
After a decree of the government of Russian Federation government N1931 temporary acted as chief of Federal Agency for consumer protection and human wellbeing from October 23, 2013.
Following a decree of the government of Russian Federation N571-p appointed head of Rospoterbnadzor.
Married, has two children

Front row participant:

Sofia Malyavina — General Director, National Priorities

Identifying a Strategy for Demographic Development by 2030: Making Decisions in an Era of Upheaval

According to a decree of the President of the Russian Federation «On the country’s national development goals until 2030», the life expectancy of Russians by the target date should increase and reach 78 years. Such goals require the restoration of economic growth and improvements in social well-being and public health. The trend of dwindling birth rates remains the country’s key demographic problem. The goal of ensuring natural population growth and increasing life expectancy requires the healthcare system to implement a multidimensional review of approaches to demographic policy. These strategies are based on a whole range of tasks and the need for an integrated approach to their solutions - the equal access to high-quality and timely medical care (especially in primary care), the search for innovative solutions in medical science, the digitalization of healthcare, expanding the potential of high-tech care and others. It is still important for the government to focus on the implementation of incentive programmes to support young families and awareness-raising activities. In addition to promoting the values of a healthy lifestyle, mass physical education, and sports, an equally important task is to promote the culture of family and having several children among young people.
• What strategies should the government develop to overcome the consequences of the pandemic and ensure stability in demographic processes?
• How can we create an effective reproductive health system?
• What new models of healthcare will be able to provide an effective policy for the protection of motherhood and childhood?
• What measures can be used to reorient society towards a conscious desire to lead a healthy lifestyle and take care of their health?

Moderator:

Oleg Apolikhin — Director, N.A. Lopatkin Research Institute of Urology and Interventional Radiology, a branch of the National Medical Research Centre for Radiology of the Ministry of Health of the Russian Federation

Apolikhin O.I. is a graduate of Voronezh State Medical Institute and has received his MD from the Scientific Research Institute of urology of the Health Ministry of Russia. He extended his education with several abroad trainings: Medical Technical University (ACTIM) France, Medical and Economic faculty, course in health care economics and new technologies and modern equipment utilization. Oxford University (England), MBA faculty, course in medical ethics and administrative law in health care. Oxford University (England), course in evidence based medicine. Professor Apolikhin is actively involved in state health care structure being chief specialist in Reproductive Health of the Ministry of Health Care of Russia. He systematically holds scientific, organizational and methodical activity in reproductive health in Russian regions. Professor Apolikhin has been recognized nationally and internationally through his international memberships which include European Urological Association, American Urological Association and Royal Society of Medicine (UK). He studied Administrative ethical issues in health care at Oxford University, where he also received MSc in evidence-based health care. Professor Apolikhin holds editorial positions on several well-respected journals, including Russian Journal of Urology. He has authored and co-authored more than 500 articles, edited and co-edited 10 books, has multiple multimedia presentations to his credit. His extensive experience in the field of urology and andrology has afforded him the opportunity to participate in academic activities, meetings and courses as a speaker and chairperson. Fields of his interest are postgraduate medical education upgrading, modernization of Russian health care system, men’s health evaluation and management.

Panellists:

Nikolay Govorin — Deputy Chairman of the Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection

Oleg Kuvshinnikov — Governor of the Vologda Region

Mr. Kuvshinnikov was born in Cherepovets in 1965. He was actively involved in sport in his childhood and youth. He is a candidate master of sports in hockey. 1982 – Began working at Cherepovets Metallurgical Plant. 1985–1987 – Served in the Soviet Army. Military rank – sergeant. 1987 – Worked at Cherepovets Metallurgical Plant as the operator of the 250 Mill in the rolling shop. 1994 – Foreman of the rolling shop, then head of the 250 Mill and later deputy head of the production shop. 2000 – Head of the rolling shop. 2002 – Head of Sheet Rolling Shop No. 1. 2002–2006 – Deputy of the Cherepovets City Duma and Chairman of the Urban Affairs Committee. 2003 – Member of the United Russia party. 2004–2005 – Member of the Board of Directors of Severstal. 2004–2006 – Director of Social Amenities at Severstal. 2006 – First Deputy Mayor and acting Mayor of Cherepovets. 2007 – Elected Mayor of Cherepovets (65.3% of votes). 2007 – Member of the political council presidium of the Vologda regional branch of the United Russia party. December 2011 – Governor of the Vologda Region. May 17, 2014 – Acting Governor of the Vologda Region. September 23, 2014 – Elected Governor of the Vologda Region (62.98% of votes). Education: 1991 – Yaroslavl College of Soviet Trade. 1994 – St. Petersburg Trade and Economics Institute. 1999 – State University of Management in the ‘Production Management’ programme (Moscow). 2002 – Completed a training course in a corporate programme for the training of ‘Top 100’ managers. 2005 – Completed training in a MBA programme at the Academy of National Economy under the Russian Government.

Anna Kuznetsova — Presidential Commissioner for Children’s Rights

Oleg Nikolaev — Governor of the Chuvash Republic

Yves Rossier — Ambassador Extraordinary and Plenipotentiary of the Swiss Confederation to the Russian Federation

Yves Rossier has been Ambassador of Switzerland to the Russian Federation since February 2017. In 2012-2016, he served as State Secretary of the Swiss Federal Department of Foreign Affairs. In 2004-2012, he was Director of the Federal Social Insurance Office. In 2000-2004, he was Head of the Secretariat of the Federal Gaming Board. In 1998-1999, he was Political Advisor to Federal Councillor Couchepin and in 1994-1998 Scientific Advisor to Federal Councillor Delamuraz at the Federal Department of Economic Affairs. In 1993, he served as a Diplomatic Trainee at the Federal Department of Foreign Affairs. In 1990-1993, he worked as a legal adviser in the Integration Office. In 1989-1990, he passed a lawyer’s training at Froriep, Renggli & Partners. In 1986-1987, her worked as an assistant lecturer in Private International Law at the University of Fribourg (Switzerland). He has a Bachelor of Laws from the University of Fribourg (Switzerland), a Diploma in Advanced European Studies from the College of Europe, Bruges (Belgium) and a Master of Laws from the McGill University, Montreal (Canada). He was born in 1960 in Delémont (Switzerland), is married and has 5 children.

Oleg Salagay — Deputy Minister of Health of the Russian Federation

Oleg Salagay, Candidate of Medical Sciences, Director of the Department of Public Health and Communications of the Ministry of Healthcare of the Russian Federation, Press Secretary of the Minister of Healthcare of the Russian Federation Veronika Skvortsova.
Born on 3 October 1983 in Irkutsk (Irkutsk Oblast).
In 2005, graduated with honours from Irkutsk State Medical University.
In 2006, graduated with honours from the Academy of Labour and Social Relations, Department of Law.
In 2010, graduated with honours from the Diplomatic Academy of Russian Foreign Ministry.
In 2011, received a Master’s Degree in European Law from Moscow State Institute of International Relations (MGIMO University) under the Ministry of Foreign Affairs of the Russian Federation.
Oleg Salagay is a member of many working groups under the auspices of the World Health Organization, BRICS, and bilateral cooperation. He is Chairman of the Conference of the Parties to the Framework Convention on Tobacco Control.

Front row participants:

Igor Buhtiyarov — Director, Izmerov Research Institute of Occupational Health

Kirill Litovchenko — Head, Expert Center for Demographic Policy and Reproductive Health, Delovaya Rossiya (Business Russia)

Alexander Mokhov — Head of the Medical Law Department, Kutafin Moscow State Law University (MSAL)

Natalia Solovieva — Chairman, Association of Patients with Infertility

Evgeniy Shpeer — Medical Director of Vaccines, GSK Pharma Russia

Sergey Shulgin — Deputy Head of Research Laboratory for Science, International Laboratory of Demography and Human Capital, Institute of Applied Economic Research, Russian Academy of National Economy and Public Administration(RANEPA)

COVID-19 Vaccine: Working Towards the Goal

The pandemic has taken a heavy toll on the economy and public health around the world. To date, more than 21.5 million people have already been infected, and trillions of dollars in economic damage have been caused. Today, the world has accumulated scientific potential at the level of multinational pharmaceutical giants, small companies, and academic institutions in order to produce a vaccine that then has to be developed and brought to the international market in an unprecedented short time. The WHO has created an international platform to record clinical trials in order to coordinate and consolidate global efforts. Around 150 vaccines are currently being developed worldwide. In Russia, 17 research centres are working on vaccines, more than 26 types of vaccines are being developed. On 11 August 2020, the Russian Ministry of Health registered the world’s first Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. The third stage of research on this vaccine is currently under way. In the near future, the second stage of successful clinical trials will be completed at the VECTOR State Research Centre of Virology and Biotechnology, after which post-registration studies of the drug will begin at the St. Petersburg Research Institute of Vaccines and Serums under the Federal Biomedical Agency and the Smorodintsev Research Institute of Influenza, which were among the first to begin clinical trials of drugs and have become national leaders in the creation of vaccines. The diversification strategy that is being applied worldwide and involves the development of several types of vaccines all at once has enabled us to adhere to the humanistic principles of efficacy and safety and to also identify the most promising areas for development. In the near future, the WHO should receive data on 8 to 9 vaccines in order to secure provisional pre-qualification, which will allow the authorities to launch a mass vaccination programme that may begin in the next month.
• To what extent should vaccines be produce to satisfy the Russian market? Does the country have sufficient industrial capacity to provide this volume?
• What is a realistic timeframe for the mass vaccination of Russians to begin? What criteria should be taken into account when developing a vaccination plan?
• Get vaccinated or get sick: what is the advantage of vaccination over the development of natural immunity?
• What government decisions are needed to meet the need for vaccines at the level of all the regions? Does the government plan to participate in funding for universal vaccination against COVID-19?

Moderator:

Sergey Brilev — Anchor, Deputy Director, Russia TV Channel; President, Bering Bellingshausen Institute for the Americas

Russian TV presenter, writer and public figure. Deputy Director of the Rossiya TV channel for special informational projects, President of the Bering-Bellingshausen Institute for Both Americas (Montevideo), member of the Praesidium of the Foreign and Defence Policy Council (Moscow), the only Russian journalist to have interviewed both the last two Presidents of the Russian Federation and the USA: Putin and Medvedev, Bush and Obama.
Born 24 July 1972 in Havana (Cuba).
Graduated from MGIMO MID RF (1995, Moscow), the Montevideo Institute of Foreign Languages (1991, Uruguay), and finished BBC courses (1995, London).
Career:
1990–1993: Komsomolskaya Pravda. Trainee, scholarship holder, correspondent-intern in the department of science and education.
1993–1995: Moscow News. International department special correspondent. In parallel, Moscow correspondent of the Uruguay El Observador Económico and the Argentinian La Razón, as well as Russian State Duma Latin America expert.
Since 1995: Rossiya (RTR) TV channel, including:
1995–1996: Vesti special correspondent (including during the First Chechen War).
1996–2001: Bureau Chief in London.
First broadcast as presenter on 11 September 2001 (day of the terrorist acts in the USA).
2001–2003: presenter of evening Vesti.
2003–2007: presenter of Vesti Nedeli, Deputy Director, Directorate of information programmes.
Since 2008: presenter of the Vesti on Saturday programme, Deputy Director of Rossiya TV channel.
Author of a multitude of documentary films: Secret of Three Oceans, Constitutional Practice, Duma Thinking, Right to Right, Heavy Oil, Another Coal, The Caribbean Crisis. An Incomprehensible Story, Nazarbayev’s Line, etc.
Author of the books: Forgotten Allies in World War II (2012) and Fidel. Football. Falklands (2008).
One of the main spheres of his professional activity is interviewing heads of state. In particular, in Latin America: Chavez (Venezuela), Ortega (Nicaragua), Correa (Ecuador), Morales (Bolivia), Sanguinetti (Uruguay), Bachelet (Chile) and so on.
By order of the Russian President, awarded the Order of Friendship, the medals 300th Anniversary of St. Petersburg and 1000th Anniversary of Kazan (2005). Was the finalist and winner of the TEFI awards many times.
Speaks English and Spanish fluently.

Panellists:

Melita Vujnovic — Representative to the Russian Federation, Head of Office, World Health Organization Office in the Russian Federation

Anna Popova — Head, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Front row participants:

Igor Borisevich — Deputy Head, Federal Medical-Biological Agency of the Russian Federation

Ekaterina Efimova — Head of Social Projects, National Priorities

Aydar Ishmukhametov — Doctor of Science in Medical Sciences, Professor, Corresponding Member of Russian Academy of Science; Director General, Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences

He has graduated (in 1980) the First Moscow State Medical University (Sechenov University), where he later worked (1980-2012).
He is the Candidate of Medical Science (1985) and the Doctor of Medicine (2001).
Since 2013 – the Director General of the Federal State Budgetary Scientific Institution «Chumakov Federal Scientific Center for Research & Development of Immune-and-Biological Product» (FSBSI Chumakov FSC R&D IBP RAS) of the Ministry of Science and Higher Education (Russia). Since 2017 – the head of the subdepartment of the organization and technology of immunobiological preparations production of the First Moscow State Medical University.
Was chosen as the RAS corresponding member in medical sciences department («Pharmacy Organization» specialty) (2016).
Under the leadership of A.A. Ishmukhametov there was developed a unique methodology for the production of information and analytical systems reflecting the actual state of the pharmaceutical industry. It includes the latest statistical data processing techniques and data extrapolation algorithms adapted to the characteristics of the pharmaceutical market. Creation of a fundamentally new analytical content, enabling multifactor analysis and scientific forecasting of economic phenomena in the pharmaceutical market, makes it possible to more effectively solve the problems of the industry. There are formulated and substantiated the basic principles of creating a unified information environment in the field of circulation of medicines.
In 2014, he proposed and implemented the Chumakov Center development concept, which made it possible to combine the scientific, technological and production aspects of creating and introducing into the circulation the original innovative national immunobiological preparations, such as prevention vaccines for the polio, tick-borne encephalitis, yellow fever, which are included in regional immunization calendars. The reorganization of the enterprise’s business processes has carried out with the introduction of quality management principles in biopharmaceutical enterprises. This has made it possible in the shortest possible time to completely modernize the enterprise, obtain a GMP certificate, solve the problems of import substitution and to develop new biopharmaceutical and immunological preparations, some of which have already passed preclinical and clinical studies. As the result, the company has increased its output and exports of the preparations.

Lessons from the Pandemic: Time for Quick Decisions Without Any Room for Mistakes

The 2020 pandemic disrupted the normal lifestyle of millions of people overnight, splitting time into ‘before’ and ‘after’, and forever altering political, economic and social life. Perhaps historically it will be thought of as a crisis that led to a global reboot of all systems. Everyone faced unprecedented challenges – states, business, society, and every single person. The key factors in the successful response to the pandemic were the speed of decision-making by the public authorities and the effectiveness of the healthcare system, which showed resilience and flexibility and was able to respond to global challenges with a number of effective solutions. One of the results of the global transformations in the industry is the way in which society’s attitude towards doctors has changed, with medicine turning from a service sector into a safety zone. The 2020 crisis has hit the economy hard and has forced businesses to show strategic flexibility and significantly reshape existing business models and develop effective long-term strategies that can confront new economic challenges. The epidemiological situation has forced most companies to shift employees to a new work mode, which has become a requisite precondition for reformatting the labor market and the emergence of numerous socially oriented initiatives. The most important changes have affected social models and value systems, as the needs of other people have become the focus of attention, and the importance of human life has become the main value of this year.
The lessons of the pandemic have set the stage for future progressive changes, which are already overdue.

• What global health reforms have the pandemic identified as essential?
• Has the healthcare system been able to develop immunity to future emergencies and is it ready to respond to sanitary and epidemiological challenges?
• Will the pandemic accelerate the transition of the health system to a patient-centered approach?
• Does the Russian economy have enough potential to overcome the pandemic crisis and achieve the national goal of protecting the population along with people’s health and wellbeing?
• What areas of entrepreneurship development are most likely in the ‘post-crisis era’ and will businesses be able to build sustainable business models in the new reality?
• Will the increased stress factors during the year of the pandemic affect people’s physical and psychological health in the future?
• Will the social initiatives that emerged during the pandemic become the norm for the socioeconomic model of the future?

Moderator:

Alena Rogozina — Special Correspondent, Russia-1 TV Channel; Nominee for TEFI National Television Award

Panellists:

Yuriy Zhulev — President, Russian Hemophilia Society

In 1985, graduated from the school number 856 (Moscow).
In 1991, graduated from the Moscow State Law University.
In 1989, he was elected Vice President of Hemophilia Association (later renamed Hemophilia Society) that was established the same year.
Since 1993, he was the President of the Hemophilia Society.
In 2000, at the founding congress of the Russian Hemophilia Society he was elected its President, and he still holds this position.
In 2002–2004, he was a board member of the European Hemophilia Consortium and member of the World Federation of Hemophilia. He was named ‘Best volunteer’ of the World Federation of Hemophilia for his active work in CIS countries.
At present, he also holds the following positions:
• Co-chairman of the Russian Union of Patients Public Societies;
• Member of Commission for the Disabled under President of the Russian Federation;
• Head of the working group for improvement of the state sociomedical assessment system and monitoring of implementation of decisions made for the Commission for the Disabled under President of the Russian Federation;
• Co-chair of the Council of public agencies for patients’ rights for the Ministry of Health of the Russian Federation;
• Deputy Chairman of the Public Council of the Ministry of Health of the Russian Federation;
• Member of Council of public agencies for patients’ rights for Federal Service for Surveillance in Healthcare;
• Member of Moscow’s regional department of All-Russia People's Front.
Yury Zhulyov was awarded with an honorary certificate by the Ministry of Health of the Russian Federation, an honorary certificate by the Federal Service for Surveillance in Healthcare and Social Development.

Georgy Kostyuk — Chief Physician, Alekseyev Psychiatric Clinical Hospital No. 1 of the Moscow City Health Department

Andrei Nazarov — Prime Minister of the Government of the Republic of Bashkortostan

Andrey Nikitin — Governor of Novgorod Region

Born in 1979 in Moscow.
2001 – graduated from State University of Management.
2007 – was awarded EMBA degree at Stockholm school of Economics.
2002-2011 – held key positions in Ruskompozit Group of companies composed of the largest Russian enterprises which do business in the markets of glass fibre, composite and geosynthetic materials.
2009 — was appointed Director General of Ruskompozit Management Company LLC.
Since 27.07.2011 – held a position of the CEO of the Agency of Strategic Initiatives (ASI).
13.02.2017 – was appointed the acting governor of the Novgorod region by the Presidential Decree.
Member of the Presidium of the Council under the President of the Russian Federation for economic modernization and innovative development of Russia.
Member of the Presidium of the Presidential Council for Strategic Development and Priority Projects.
Member of the Supervisory Board of the Agency for Strategic Initiatives to Promote New Projects.
Awarded the Order "For Merit to the Fatherland" II class and the Russian Federation Presidential Certificate of Gratitude.
Ph.D. degree in Economics.
Married.

Ekaterina Pogodina — Director General, Johnson & Johnson Russia & CIS, Managing Director, Janssen, pharmaceutical division of Johnson & Johnson, Russia & CIS

Katerina began her career with Janssen in 2001, holding a number of positions in the Sales, Marketing and Market Access teams. She has been a member of the Russian board of directors since 2010 and was appointed Country Manager Russia in 2015, and then she was promoted to the position of Managing Director Russia & CIS in 2017. In April 2019 Katerina was appointed CEO of Johnson & Johnson Russia & CIS.

Throughout her 17-year career with Janssen, Katerina has consistently demonstrated high standards of quality and strong results. She led the launch of a whole range of new products and work across a number of therapeutic areas, as well as establishing several new business units. In her role as Commercial Operations Director, Russia, Katerina successfully led commercial teams in close collaboration with other departments, which yielded great business results and drove the company’s overall success.

Katerina graduated with distinction from the International University in Moscow, where she studied law. She also completed specialist education for senior executives at the London School of Economics and Political Science and Moscow School of Management Skolkovo.

Since 2015 Katerina has been a member of the board of directors of the Association of International Pharmaceutical Manufacturers (AIPM). Forbes magazine contributor, speaker of the Second Eurasian Women’s Forum.

Front row participant:

Mikhail Shumakov — Deputy General Director for Strategy and Content, National Priorities

Type 2 Diabetes: A Key Focus of Public Responsibility

According to WHO forecasts, diabetes will be the seventh leading cause of death on the planet by 2030. The number of cases is constantly growing, which increases the financial burden on national economies. In Russia, the number of patients with diabetes has increased by 23 percent over the past five years and stood at 4.8 million people in 2019. The trend towards obesity and set patterns of social behaviour, such as sedentary lifestyles, bad habits, and unhealthy diets, are contributing to the unhindered spread of type II diabetes. Today, as we combat the new coronavirus infection, studies of the aggravating factors of COVID-19 have shown that about 25% of people with a severe form of the disease suffered from diabetes. Considering that high blood sugar weakens the immune system, people with diabetes are at increased risk of complications. Over the period from 1996 to 2012, Russia implemented the federal targeted programmes ‘Diabetes Mellitus’ and ‘Prevention and Control of Socially Significant Diseases’. The measures that were carried out significantly reorganized and structured the diabetological service and helped to increase the life expectancy of patients with diabetes to 74.1 years.
• What should the federal targeted programme to combat diabetes aim to achieve first and foremost?
• How can the percentage of disability among patients with Diabetes Mellitus be reduced?
• How can we raise public awareness about the disease and develop a responsible attitude to people’s own health?
• How can we reduce the risk of severe coronavirus in diabetic patients?
• What additional preventive measures are required for patients with diabetes?
• What effective practices in this area are the regions ready to implement?

Moderator:

Evelina Zakamskaya — Editor-in-Chief, Doctor Channel; Anchor, Russia 24

Panellists:

Joao Breda — Head of the European Office, World Health Organization for the Prevention and Control of NCDs

Francesco Giorgino — President, Italian Society of Endocrinology (SIE); Professor of Endocrinology and Chief, Division of Endocrinology University Hospital Policlinico Consorziale, University of Bari Aldo Moro

Francesco Giorgino is Professor of Endocrinology and Metabolism and Chairman of the Department of Emergency and Organ Transplantation at the University of Bari Aldo Moro, Bari, Italy. He is also Chief of the Division of Endocrinology at the University Hospital Policlinico Consorziale in Bari, Italy. Professor Giorgino received his M.D. degree from the University of Bari Aldo Moro and his Ph.D. degree from the University of Naples Federico II, in Italy. After completing clinical and research training in endocrinology and metabolism at the University of Catania, Italy, he worked for several years at the Joslin Diabetes Center and Harvard Medical School in Boston, MA, USA, first as a postdoctoral research fellow and then as a visiting scientist.

Professor Giorgino has received distinguished scientific awards from various international and national institutions, including the Juvenile Diabetes Research Foundation International (JDRF) Fellowship (New York, NY, USA), the Mary K. Iacocca Foundation Fellowship (Boston, MA, USA), the Glaxo-Wellcome Award from the European Association for the Study of Diabetes (EASD), the Aldo Pinchera and Cassano Awards from the Italian Society of Endocrinology, and the Alcmeone Award from the Italian Society of Diabetology. He has been the Italian Delegate in various European Commission Cooperation in Science and Technology (COST) actions for diabetes research. Professor Giorgino has served on many national commissions and national boards, including the Executive Committees and Scientific Committees of the Italian Society of Diabetology and of the Italian Society of Endocrinology. He is currently President of the Italian Society of Endocrinology.

He is or has been a member of the Editorial Boards for the following journals: PLoS ONE, Journal of Endocrinology, Endocrinology, Journal of Endocrinological Investigation, Adipocyte, Acta Diabetologica, Cardiorenal Medicine, and Diabetes Metabolism Research and Reviews. He has published more than 200 original and review articles in prestigious scientific journals and has been an invited speaker at many national and international meetings. Professor Giorgino’s research interests include the mechanisms leading to insulin resistance and beta-cell dysfunction in type 2 diabetes with a particular focus on skeletal muscle metabolism and organ cross-talk, inflammation and lipotoxicity, and the effects of diabetes drugs on pancreatic islets and the cardiovascular system. He has also been involved in several clinical trials investigating the effects of glucose-lowering drugs in individuals with type 2 diabetes. He has an H-index of 58 and over 11,000 citations (Google Scholar).

Hans Duijf — Vice-President, Russia and Belarus, Novo Nordisk

Hans Duijf was appointed Vice President of Novo Nordisk in Russia and Belarus since September 1, 2017.
Mr. Duijf is a Dutch national, born in June 1974. He moved to Moscow with his family, wife and two daughters, from Colombia, where he held the position of General Manager of the Novo Nordisk affiliate since 2015.
Mr. Duijf has nearly 20 years of experience in the affiliates and regional headquarters of Novo Nordisk in established and developing markets in Europe, South-East Asia and Latin America. Under his leadership diverse teams of different cultures consistently succeeded in improving performance and introducing innovative approaches. Mr. Duijf began his career in sales and marketing in the UK, and later participated in the product launching in the markets of different countries. He has extensive management experience in positions such as Marketing Director, Business Development Director, General Manager, Vice President.
Hans Duijf has received education in international marketing and strategic management and holds a Master of Science (M.Sc.) degree in Business Administration from Rotterdam School of Management, Erasmus University in the Netherlands.

Oliver Koehncke — General Director, Boehringer Ingelheim Russia

Alexander Mayorov — President, Russian Diabetes Association

Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology

Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.

Oleg Salagay — Deputy Minister of Health of the Russian Federation

Marina Shestakova — Deputy Director of the Center- of the Diabetes Institute, Endocrinology Research Centre of the Ministry of Health of the Russian Federation

Front row participants:

Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation

Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks

Andrey Prilutskiy — Minister of Healthcare of Ryazan Region

Patimat Khandaeva — Chair, Russian Young Endocrinologists Society (RYES)

Countering COVID-19: New Formats in the Fight against Cancer

The healthcare system has faced an unprecedented challenge since the start of 2020. In order to combat coronavirus, several medical institutions have had to be repurposed in a short time, while maintaining the availability of medical care for cancer patients. In the context of mitigating the consequences of the 2020 pandemic, one of the key goals of the national project to reduce mortality from neoplasms not only requires the active introduction of advanced methods of prevention, diagnosis, and therapy into medical practice, but also the creation of an ecosystem for cancer care, the development of fundamentally new approaches to such care, tools for expanding access to therapy, and the introduction of innovative funding models by connecting businesses and sharing risks. Such new formats include the launch of a network of Outpatient Oncological Care Centres in the regions as well as a vertically integrated system that allows for ensuring continuity between institutions, prescribing the most modern treatment to the patient, and, if necessary, requesting a second opinion. In 2020, the federal project to combat cancer includes oncohematology. Thanks to the use of advanced modern drug therapy, patients with lymphatic and hematopoietic tissue neoplasms are more likely to receive effective medical care compared with other cancer patients.
• What new approaches and tools have been the most effective in providing healthcare during the pandemic?
• What solutions have become the basis for the development of a new paradigm of cancer care?
• How can the availability of diagnostics and modern therapy be enhanced for cancer patients?
• What tools are being implemented in Russia for the development of outpatient oncology?
• How will AI and innovative technologies change the way cancer patients are treated?
• How promising is the idea of introducing innovative financial solutions and attracting private investment and valid for the development of cancer care?

Moderator:

Alexander Petrov — Chairman of Subcommittee on Medicines Circulation, Pharmaceutical and Medical Industry Development, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection

Panellists:

Valery Elykomov — Deputy, Member of the Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection

George Zaki — Head of Oncology, EEMEA MSD

Andrey Kaprin — Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.

Alexander Petrovskiy — Deputy Director for Educational Activities, National Medical Research Center of Oncology named after N. N. Blokhina of the Ministry of Health of the Russian Federation

Front row participants:

Alisa Dzhangiryants — Director of Market Access and Pricing, Bristol-Myers Squibb

Dmitry Kudrumov — First Deputy Chairman of the Government of Kirov Region

Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Aleksandr Rumyantsev — President, Dmitry Rogachev National Research Centre

Alexander Rumyantsev, born in 1947, is a Russian Doctor of Medical Sciences, professor, member of the Russian Academy of Sciences, General Director of the Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, member of the Board of the ‘Doctors, Innovation and Science for Children’ Foundation that supports the development of Pediatric Hematology, Oncology and Immunology, chief consulting pediatric hematologist of the Ministry of Health of Russia, President of the National Society of Pediatric Hematologists and Oncologists, Chairman of the Board of the National Association of Experts in Primary Immunodeficiency, Vice President of the National Medical Chamber, Honorary Professor of the Department of Oncology and Hematology of the School of Pediatrics of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. Graduated with honours from the Russian National Research Medical University named after N.I. Pirogov in 1971.
Alexander Rumyantsev is an active facilitator of medical science and practice. For years he headed the RSMU scientific programmes on leukemia in humans and animals of the USSR Committee for Science and Technology and research on rectifying the consequences of Chernobyl disaster, was a member of the Academic Council of the Academy of Medical Sciences and the Ministry of Health of the USSR on pediatrics, hematology and oncology. From 1989 to the present day he has been a Chairman of the hematology section of the Moscow Society of Pediatric Physicians. He is a participant of the Chernobyl nuclear disaster elimination team (1986–1987), ‘Children of Chernobyl’ research programme facilitator in the USSR (1990–1991) and in Russia (1991–1995). Rumyantsev for twenty five years has led pediatric hematology/oncology services in Russia, the process of preparation and adoption of the industry development and financing programme, successful treatment of leukemia, malignant lymphomas, brain tumours, other neoplasms in children and adolescents, setting up a course on pediatric hematology/oncology in the School of Continuing Medical Education in RSMU (the Department of Clinical Hematology/Oncology and Immunology of the School of Continuing Medical Education in RSMU since 2004, and the Department of Oncology and Hematology of the School of Pediatrics of the RSMU), the groundwork for academic programme, the training and certification of pediatric hematologists/oncologists in the Russian Federation.
As a researcher, Alexander Rumyantsev is known for his works in pediatric hematology and immunology, medical ecology, intensive and outpatient pediatrics, adolescent medicine and organization of public health, clinical physiology and pathophysiology of blood, regulation of hematopoiesis and immune response, pathogenesis and treatment of hereditary and evoked blood diseases in children, intensive polychemotherapy and immunotherapy of leukemia. Alexander Rumyantsev is the author of more than 650 scientific papers, including 45 monographs and manuals. He is a member of the Scientific Council and the head of the scientific platform ‘Oncology’ of the Ministry of Health of the Russian Federation, the editor-in-chief of the Bulletin of Blood Service in Russia journal, a member of editorial boards of the following journals: Pediatrics, Russian Pediatric Journal, Issues of Practical Pediatrics, Issues of Dietary Therapy In Pediatrics, Issues of Hematology/Oncology And Immunopathology In Pediatrics, Hematology And Transfusiology, Russian Journal of Pediatric Hematology and Oncology, School of Health, Russian Journal of Immunology; member of the Pharmaceutical Committee of the Russian Federation; member of the National Council of Experts on Rare Diseases, advised 70 doctors and 128 candidates of medical sciences. Honourable Laureate of the Russian National Research Medical University awards (1978, 1983, 1994, 2007), of the Maslov Academy of Medical Sciences of the USSR (1978), of the Moscow Komsomol (1979) for the research in hematology and immunology. He was awarded with a participant’s diploma and a silver medal of the VDNKh (All-Union Exhibition of Achievements of National Economy) (1989) for development of diagnostics and immunotherapy of blood diseases in children, and with an honorary medal of the University of Montpellier (France, 1990). In 1994 he was awarded the Order of Friendship of Peoples for his scientific and academic work, in 2002 – the Honorary Diplomas of the State Duma of the Russian Federation and the Moscow City Duma, in 2003 and 2015 – ‘The Calling’ Award for the best doctors in Russia, in 2004 – the medal ‘For Merits in Healthcare’, in 2007 – Excellent Worker of Public Health badge. In 2008 and 2011 he received the medical awards from the Moscow government, in 2013 – the International Galien Award. In 2015 he was awarded the Glory of Ossetia Order and the Russian Emergencies Ministry (EMERCOM) medal ‘Cooperation for Salvation’.
Married with two children and five grandchildren.

HIV and COVID-19: Enhanced Risk Control

Even with the challenges that the 2020 pandemic has caused for national health systems, we must not forget that the spread of HIV is one of the most significant global problems that pose a threat to the health and life of the global population. According to the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, the number of people with HIV in Russia this year has already exceeded 1 million people. Per the temporary recommendations of the Russian Ministry of Health on the prevention, diagnosis, and treatment of the novel coronavirus infection, patients with immunodeficiency conditions, including HIV without antiretroviral therapy, are at risk. In the context of the pandemic, the sufficiency and continuity of antiretroviral therapy during isolation as well as the provision of measures to reduce and prevent the risk of infection has taken on even greater importance. In an effort to study the effects of the new coronavirus pandemic on medical assistance for HIV treatment, the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing launched a nationwide study to identify the number of HIV-infected Russians who have had COVID-19, the testing experience on COVID-19, and whether there are risks of being infected with coronavirus and suffering comorbidities.
• Will the COVID-19 pandemic cause an increase in the number of people living with HIV in the near future and can its impact be prevented in this case?
• Are the measures being taken sufficient to achieve the goals of the government’s HIV spread prevention strategy?
• What new solutions are needed to improve the effectiveness of measures to reduce the number of new HIV infections and AIDS-related deaths?
• What measures can be implemented to ensure the availability of antiretroviral drugs during the pandemic?
• What impact has the use of HIV drugs for coronavirus treatment affected their availability?

Moderator:

Elena Voytsekhovskaya — Anchor, Doctor Channel

Panellists:

Marwan Akar — Managing Director, MSD Russia and EAEU

Г-н Акар начал работу в MSD в качестве инженера-технолога производства. По мере развития карьеры он занимал разные должности с возрастающей сферой ответственности, руководил проектами по трансферу технологий производства вакцин и других лекарственных препаратов, способствовал наращиванию производственных мощностей MSD и компаний-партнеров по всему миру.
В 2008 году г-н Акар был назначен на пост руководителя операций производственного подразделения MSD в регионах «Восточная Европа, Ближний Восток и Африка» и «Европа и Канада». В этой роли он поддерживал стратегические проекты по развитию бизнеса, а также отвечал за партнерства с локальными производителями, в том числе в России.
Г-н Акар получил диплом магистра в Мэрилэндском университете (США) по специальности «Химик-технолог». Он также закончил обучение по программе МВА (Магистр делового администрирования) в Имперском колледже Лондона.

Igor Borisevich — Deputy Head, Federal Medical-Biological Agency of the Russian Federation

Oleg Gridnev — Deputy Minister of Health of the Russian Federation

Alexey Mazus — Chief External Expert in HIV Diagnosis and Treatment of the Ministry of Health of the Russian Federation

Nicole Seguy — HIV and Hepatitis Unit Lead, World Health Organization Regional Office for Europe

Front row participants:

Denis Godlevsky — Director, Regional Public Organization "AIDS, Statistics, Health"

Yulia Godunova — Director, EVA Association

Denis Gusev — Chief Doctor, Clinical Infectious Diseases Hospital named after S.P. Botkin

Kamil Saytkulov — Head of Communications and Government Affairs, GSK Russia

Vladimir Chulanov — Deputy Director for Research and Innovation Development, National Medical Research Center for Phtisiopulmonology and Infectious Diseases; Chief External Expert in Infectious Diseases of the Ministry of Health of the Russian Federation

Rafael Yapparov — Chief Doctor, Republican Center for Prevention and Control of AIDS and Infectious Diseases, Republic of Bashkortostan; Chief External Expert in HIV of the Volga Federal District

Caring for the Older Generation as an Important Focus of Social Policy: The Challenge in Times of the Current COVID-19 Challenge

Maintaining an active long life and providing high-quality medical care to the elderly are important issues that shape national healthcare and social policy. In the midst of the spread of the coronavirus, older people have been exposed to greater risk, this requiring the state to develop special measures for keeping them healthy and reducing fatalities. The experience of the pandemic has shown that the State should pay close attention to all aspects that can affect the health and quality of life of older people. One way of reducing mortality and helping the elderly to maintain an active lifestyle is to prevent age-related diseases. Measures to protect the health of people beyond working age are reflected in the Federal Project “The Older Generation” of the “Demography” national project. It is a comprehensive approach and policy aimed at improving medical care for the older generation, which can become a key factor in achieving the national goal of preserving the population, health and well-being of people and increasing life expectancy in Russia.
• What state policy measures in relation to older citizens should ensure attainment of national goals of preserving health and increasing life expectancy?
• What solutions and cutting-edge technologies can increase the quality of medical and preventive care for the older generation?
• What new trends and innovative approaches in healthcare are most relevant for slowing down the rate of aging and increasing life expectancy?
• Does the Federal Project “The Older Generation” need to adjust the action plan in order to improve the quality of medical care for elderly patients?

Moderator:

Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Panellists:

Alexander Gubin — Director, National Medical Research Center for Traumatology and Orthopedics named after N.N. Priorova of the Ministry of Health of the Russian Federation

Aleksandr Rozanov — Head, Federal Center for Coordination of the Activities of the Subjects of the Russian Federation for the Development of the Organization of Medical Care in the Geriatrics Profile

Olga Tkacheva — Director, Russian Clinical and Research Center of Gerontology of the Pirogov Russian National Research Medical University (RNRMU) of the Ministry of Health of the Russian Federation

Olga Tkacheva graduated with honours from S.M. Kirov Gorky State Medical Institute majoring in General Medicine and the therapy internship in S.M. Kirov Gorky State Medical Institute. In 1993, Olga Tkacheva was awarded the scientific degree of Candidate of Medical Sciences, in 1999 – Doctor of Medical Sciences. In 2006, she earned the title of professor. Ms Tkacheva has 32 years of clinical work experience and 28 years of teaching under her belt.
From 2013 to 2018 – Senior Geriatrician of the Ministry of Healthcare of the Russian Federation. From 2015 – present – contracted Chief Geriatrician of the Ministry of Healthcare of the Russian Federation and Director of Russian Clinical Research Centre for Gerontology. She is the author of more than 300 scientific publications, 11 monographs, national guidelines, has one certificate and three patents for inventions.
She headed the working groups and was a member of expert committees on the preparation of national guidelines ‘Diagnosis and treatment of hypertension’, the recommendations on diagnosis and treatment of hypertension in pregnant women, national guidelines on diagnosis and treatment of cardiovascular diseases during pregnancy, guidelines on general risk reduction of disease and complications in women, practical guidelines on the use of hormone replacement therapy in peri- and postmenopausal women, national guidelines ‘Prevention of chronic non-communicable diseases’, guidelines for physicians ‘Basic Principles of the prevention and treatment of thrombosis in tables and charts’, guidelines ‘Follow-up monitoring of patients with chronic non-communicable diseases and high-risk patients’.
Olga Tkacheva’s scientific research focused on the mechanisms and patterns of the heart and blood vessels ageing and their correlation with cellular replicative ageing, the issues of the age-related metabolic disorders, prevention and treatment of age-related diseases and geriatric syndromes.
She advised on 20 candidate and five doctoral theses.
She is the president of the National Public Organization ‘Russian Association of Gerontologists and Geriatricians’, member of the National Public Organization ‘Russian Society for the Prevention of Non-Communicable Diseases’, National Public Organization ‘Russian Society of Cardiology’, National Organization ‘Russian Medical Society on Arterial Hypertension’, National Medical Society of Preventive Cardiology, European Society of Cardiology, European Geriatric Medicine Society.
She is a member of the editorial board of medical journals ‘Rational Pharmacotherapy in Cardiology’, ‘Preventive Medicine’, ‘Clinical Gerontology’, ‘Archives of Internal Medicine’, ‘Medical Care’, ‘Women’s Health Issues’, ‘Russian Open Medical Journal’, ‘Bulletin of the Ivanovo Medical Academy’.

Front row participant:

Anatoly Ovsyankin — Chief Physician, Federal Center of Traumatology, Orthopedics and Endoprosthetics of the Ministry of Health of the Russian Federation (Smolensk)

Creative Industries for Healthy Society

Visiting lounge of the Eurasian Women's Forum Creative innovations have stepped confidently into modern healthcare: today's medical science and the healthcare system rely increasingly on a creative approach to resolving various problems. Virtual and augmented reality technologies are used for high-tech diagnostics, which can reduce the protracted patient rehabilitation process. Artificial intelligence, processing huge amounts of information, helps the physician make the right decisions, reducing the number of medical errors. With the help of digital technologies and robotics, the quality of healthcare is improved, which means a better quality of life for patients. Smart services of the Internet of medical things not only help to control health but also create conditions for convenient prevention, strengthening the vector of preventive medicine development. A creative approach to development and use of medical technologies and scientific knowledge has allowed participants in the healthcare system to apply a symbiosis of different medical practices, seek new formats for medical care and get answers to questions that recently seemed unsolvable. By attracting innovative technologies in medicine, such as access to big data, and developing genetic science with their help, it is at last possible to talk about personalised medicine, in which prevention, diagnostics and treatment methods are developed on the basis of the individual patient’s characteristics. Thanks to the industry of creative ideas, medicine may be discussed not in the context of treating patients but rather in preventing diseases and leading healthy lifestyle as social behaviour norms.
• Will the 2020 pandemic create an even more powerful impetus for integrating the creative sector with the public healthcare system?
• How can creative industries help develop the health and medical sector?
• Will integration of the creative sector into the healthcare system require improvements to the current legislation?
• What examples of successful collaboration exist today and which areas of the healthcare system require more "creative potential"?

Moderator:

TBD —

Panellists:

Galina Karelova — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation

Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology

Ekaterina Pogodina — Director General, Johnson & Johnson Russia & CIS, Managing Director, Janssen, pharmaceutical division of Johnson & Johnson, Russia & CIS

Modernization of the Personnel Support System as a Response to the Challenge of Our Times

The pandemic has highlighted significant shortcomings in healthcare systems around the world, which has contributed to the need to make serious decisions very quickly. One of the problems that became apparent in the early exponential spread of COVID-19 was a shortage in the talent pool and a shortage of physicians. It was crucial to not only solve the problem of repurposing medical institutions as quickly as possible, but also mobilizing doctors and healthcare workers to combat the novel coronavirus infection. The government managed to prepare the entire medical community to work with COVID-19 patients in a short period of time. More than one and a half million people were retrained using interactive educational modules. Volunteers and senior medical students were recruited to work in infectious diseases hospitals. The Russian government has developed measures to support doctors involved in combatting coronavirus. The experience acquired during the pandemic has resulted in unprecedented professional cohesion, but the example of the specialization of infectious disease doctors has also demonstrated the shortcomings of the staffing system and, perhaps, revealed imperfections in the highly specialized approach to the medical profession and pointed to the need to shift the focus towards an interdisciplinary approach. In President Putin’s address to the Federal Assembly of the Russian Federation, training and recruiting medical personnel as well as the availability of medical education were among the top priorities. Today, these goals have become even more relevant and important. The time has come to assess whether the current human resources are sufficient for the challenges of today’s reality.
• Will the pandemic become a catalyst for the thorough modernization of the medical training system? Will the introduction of an interdisciplinary approach become another module of medical education reform?
• What skills should the doctors of the future have?
• How can we prepare our human resources for possible future epidemics?
• Is the medical education system ready to change according to the challenges of the current times?

Moderator:

Muslim Muslimov — Founder, Klinika No. 1 Medical Centre Network; Chairman of the Committee for Medical Services, Delovaya Rossiya (Business Russia); Chairman, Association of Healthcare Managers

Panellists:

Elena Aksenova — Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department SBI

Valery Vechorko — Chief Doctor, Municipal Clinical Hospital No.15 named after O.M. Filatov of Department of Health of Moscow

Valery Vechorko graduated from Minsk State Medical Institute specializing in Medical and Preventive Care in 1999. He completed an internship in Dermatovenerology. In 2006, he underwent professional retraining at I.M. Sechenov First Moscow State Medical University, specializing in Internal Medicine. In 2010 he completed a training program Public Health and Healthcare.
In 2012 Valery Vechorko got a PhD degree in Medicine. Totally, he has been working for 20 years in Healthcare and for 9 years in Moscow Healthcare. Since June, 2016 Valery Vechorko has been managing City Clinical Hospital No. 15 named after O.M. Filatov. He is an Associate Professor of Inpatient Treatment Department of Russian National Research Medical University named after N.I. Pirogov.
In 2016 he graduated from Moscow Metropolitan Governance University and got a degree of Master of Public Administration (МРА) in Healthcare.
Valery Vechorko was awarded with the Badge of Honor Blagodaryu(Gratitude) by the Governor of the Moscow Region. He has a Certficate of Honour of the Russian Ministry of Health and numerous municipal and federal awards.
He is an Honorary Donor of Russia.
Valery Vechorko is married and has four daughters.
He has been a member of Russian political party UNITED RUSSIA since 2003.

Sergey Morozov — Governor of Ulyanovsk Region

Sergey Morozov was born on September 6, 1959 in Ulyanovsk. After graduating from high school, he worked as a machine operator at a furniture factory. He served in the Pacific Fleet from 1977 to 1980.Since 1981 he has worked at the law-enforcement bodies. He graduated from the All-Union Legal Institute with a major in law. He worked his way up from a criminal investigation inspector at the district office of internal affairs up to the head of a special anti-drug trafficking office of the Internal Affairs Department of the Ulyanovsk Region. In 1995, he was appointed head of the Internal Affairs Department of Dimitrovgrad. In December 2000 he was elected Mayor of Dimitrovgrad. In 2003, Dimitrovgrad won a federal competition and was granted the title of the “Cultural Capital of the Volga Region of 2004”. He has twice been awarded special government prizes for achievements in municipal improvements.In December 2004 Mr. Morozov was elected Head of the Administration of the Ulyanovsk Region. On March 28, 2006, the deputies of the Legislative Assembly of the Ulyanovsk Region approved Mr. Morozov’s candidacy for Governor of the Ulyanovsk Region as submitted by Russian President Vladimir Putin. On March 6, 2011, he was re-elected as Governor for a new term.Mr. Morozov has a PhD in Economy. He defended his dissertation on the subject “Formation of a socioeconomic development strategy for the region”.He is married with five children: two sons and three daughters.

Tatyana Semenova — Deputy Minister of Health of the Russian Federation

Ruslan Khalfin — Director, Higher School of Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Ruslan Khalfin is Director of the Higher School of Healthcare Management at the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, a medical doctor, Professor, winner of a State Prize of the Russian Federation in the field of science and technology, Honoured Doctor of the Russian Federation, and Actual State Councillor of Russian Federation, 2nd class. He worked for more than 30 years in healthcare in the Sverdlovsk Region. He has also worked in the central office of the Ministry of Health of the Russian Federation and the Ministry of Health and Social Development of the Russian Federation, and has held the post of Deputy Minister under three federal ministers. He has been actively involved in reforming the sector, and was one of the originators and implementers of the national ‘Health’ project. For the past 11 years he has been President of the medical insurance company MAKS-M, part of the MAKS Insurance Group. Chair of the Board of the Russia-wide public organization ‘The Russian Association for the Organization of Health and Public Health’.

Front row participant:

Victoria Madianova — Director of the Department of International Health Projects, Institute of Leadership and Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation